Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending July 2012. The report details a specific share repurchase transaction executed on July 30, 2012, pursuant to shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 1,200,000 Ordinary Shares of 25 pence each.
- Price Range: Highest price paid was 1,472.5 pence per share; lowest price paid was 1,440 pence per share.
- Treasury Holdings (Settled): 478,307,927 shares (8.74% of total issued share capital).
- Treasury Holdings (Including Unsettled): 482,607,927 shares (9.67% of current total voting rights).
- Shares in Issue: 4,991,195,049 shares (excluding treasury shares).
Material Changes
The primary material change is the reduction of outstanding shares through the purchase of 1,200,000 shares on July 30, 2012. This transaction increased the proportion of shares held in Treasury from the prior level to 8.74% of issued capital (or 9.67% of voting rights including unsettled shares). The filing does not provide comparative financial data for prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of risks and contingencies. It is a compliance disclosure confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules. The text explicitly states it does not constitute an offer or solicitation to purchase securities.
Investor Verification Checklist
- Verify the total cost of the 1,200,000 share repurchase based on the weighted average price between 1,440 and 1,472.5 pence.
- Confirm the impact of the 9.67% treasury holding on the denominator for shareholder notification thresholds under Disclosure and Transparency Rules.
- Check subsequent filings for the settlement status of the 4,300,000 shares included in the "purchased but not yet settled" count.
- Review the Annual General Meeting minutes from May 3, 2012, to confirm the remaining authority available for future share buybacks.